Exhibit 1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(f) under the Securities Exchange Act of
1934, as amended, the persons named below agree to the joint filing on behalf of
each of them of a statement on Schedule 13D (including amendments thereto) with
respect to the Common Stock of ADVENTRX Pharmaceuticals, Inc. and further agree
that this Joint Filing Agreement be included as an Exhibit to such joint
filings. In evidence thereof, the undersigned, being duly authorized, have
executed this Joint Filing Agreement this 5th day of August 2005.
XXXXXX INVESTMENTS LLC
By: Barberry Corp.
By: /s/ Xxxxxx X. Xxxxxxx
--------------------------------
Name: Xxxxxx X. Xxxxxxx
Title: Authorized Signatory
BARBERRY CORP.
By: /s/ Xxxxxx X. Xxxxxxx
---------------------------------------
Name: Xxxxxx X. Xxxxxxx
Title: Authorized Signatory
HIGH RIVER LIMITED PARTNERSHIP
By: Xxxxxx Investments LLC, General Partner
By: Barberry Corp., member
By: /s/ Xxxxxx X. Xxxxxxx
---------------------------------------
Name: Xxxxxx X. Xxxxxxx
Title: Authorized Signatory
ICAHN PARTNERS MASTER FUND LP
By: /s/ Xxxxxx X. Xxxxxxx
---------------------------------------
Name: Xxxxxx X. Xxxxxxx
Title: Authorized Signatory
ICAHN OFFSHORE LP
By: /s/ Xxxxxx X. Xxxxxxx
---------------------------------------
Name: Xxxxxx X. Xxxxxxx
Title: Authorized Signatory
[Signature Page of Joint Filing Agreement to Schedule 13D -
ADVENTRX Pharmaceuticals, Inc.]
CCI OFFSHORE CORP.
By: /s/ Xxxxx Xxxxxxx
---------------------------------------
Name: Xxxxx Xxxxxxx
Title: Authorized Signatory
ICAHN PARTNERS LP
By: /s/ Xxxxxx X. Xxxxxxx
---------------------------------------
Name: Xxxxxx X. Xxxxxxx
Title: Authorized Signatory
ICAHN ONSHORE LP
By: /s/ Xxxxxx X. Xxxxxxx
---------------------------------------
Name: Xxxxxx X. Xxxxxxx
Title: Authorized Signatory
CCI ONSHORE LLC
By: /s/ Xxxxx Xxxxxxx
---------------------------------------
Name: Xxxxx Xxxxxxx
Title: Authorized Signatory
/s/ Xxxx X. Icahn
------------------------------------
XXXX X. ICAHN
[Signature Page of Joint Filing Agreement to Schedule 13D -
ADVENTRX Pharmaceuticals, Inc.]
